Preferences for health outcomes associated with Group A Streptococcal disease and vaccination.

ABSTRACT:

Background

A 26-valent Group A Streptococcus (GAS) vaccine candidate has been developed that may provide protection against pharyngitis, invasive disease and rheumatic fever. However, recommendations for the use of a new vaccine must be informed by a range of considerations, including parents' preferences for different relevant health outcomes. Our objectives were to: (1) describe parent preferences for GAS disease and vaccination using willingness-to-pay (WTP) and time trade-off (TTO) methods; and (2) understand how parents' implied WTP for a quality-adjusted life year (QALY) gained might vary depending on the particular health outcome considered (e.g. averted GAS disease vs. vaccine adverse events).

Methods

Telephone interviews were conducted with parents of children diagn

SUBMITTER: Lee GM 

PROVIDER: S-EPMC2848145 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature